
In a decision that clears the way for schools to reopen safely next fall, U.S. health officials on Wednesday gave their final stamp of approval for Pfizer’s coronavirus vaccine to be offered to children aged 12 to 15. The decision, which makes millions more young Americans eligible for immunization, came as COVID-19 cases and deaths… read on > read on >